Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03322644
Other study ID # Mayo IRB #17-007214
Secondary ID U01DK108334
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2018
Est. completion date September 30, 2020

Study information

Verified date September 2021
Source Seattle Children's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pain is the cardinal symptom of acute recurrent and chronic pancreatitis, and available medical treatments have limited efficacy. Pain self-management programs equip patients to minimize the impact of chronic painful conditions on activity, health, and psychosocial functioning. The purpose of the current study is to pilot the use of Internet-delivered pain self-management course in adults with chronic and acute recurrent pancreatitis to generate preliminary feasibility and acceptability data to inform design of a subsequent large randomized controlled trial.


Description:

Acute recurrent pancreatitis (ARP) and chronic pancreatitis (CP) are associated with high disease burden across the lifespan. Recurring abdominal pain is the most prevalent and distressing symptom. Pain severity reduces health-related quality of life for individuals with CP and is associated with increased fatigue, anxiety and depressive symptoms, lower general health status, and reduced physical and role functioning. Medical therapies for CP pain have limited efficacy. Cognitive-behavioral interventions (CBT) offer safe and effective alternatives to pharmacological treatments for pain management. In other chronic painful conditions including gastrointestinal disorders, CBT interventions have been effective for reducing pain and pain impact including disability and depressive symptoms. CBT is traditionally provided by trained psychologists working with individual patients one-on-one or in small groups. Access to CBT is limited by availability of providers, with long waiting lists at centers offering CBT. The Internet is an ideal medium to provide pain self-management interventions that are low-cost and sustainable, and internet-based CBT has shown efficacy in children and adults with chronic pain, allowing clinics to greatly extend their reach to patients. The purpose of this study is to test the acceptability, feasibility, and preliminary efficacy of an Internet-delivered CBT pain self-management course for adults with acute recurrent and chronic pancreatitis pain.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date September 30, 2020
Est. primary completion date September 30, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Age = 18 years 2. Able and willing to provide informed consent for participation in this study 3. Meet CPDPC criteria for diagnosis of either suspected CP (CPDPC "yellow zone") or definite CP (CPDPC "red zone") 4. Have personal internet access on any device (e.g., phone, tablet, computer) 5. Has experienced pain intensity rated as 4 or higher on a 0-10 scale in the last month Exclusion Criteria: 1. Currently undergoing treatment for cancer 2. Inability to understand English well enough to complete questionnaires or to participate in treatment 3. Severe depression (i.e., indicated by a score > 22 on the Patient Health Questionnaire (PHQ-9) 4. Significant suicidal ideation (i.e., indicated by a score > 2 to Question 9 of the PHQ-9) 5. Acutely suicidal or recent history of attempted suicide or self-harm (i.e., last 12 months) 6. Currently receiving treatment with a psychologist

Study Design


Intervention

Behavioral:
Internet-based CBT intervention
The Internet-delivered Pancreatitis Pain Course consists of 5 lessons: 1) introduction, education, and symptom identification, 2) thought monitoring and challenging, 3) controlled breathing and pleasant activity scheduling, 4) activity pacing, and 5) relapse prevention and goal setting. Participants aim to complete one online lesson weekly for 5 weeks, and have up to 2 months to complete the course. Each lesson has a homework assignment to encourage participants to practice and apply skills. A coach who is part of the Seattle Children's Research Institute study team will make weekly contact with participants in the intervention arm through telephone or secure e-mail, for a period of between 10-15 minutes to encourage participants to work through the Course and apply the skills.

Locations

Country Name City State
United States Mayo Clinic Rochester Minnesota

Sponsors (5)

Lead Sponsor Collaborator
Seattle Children's Hospital Mayo Clinic, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Ohio State University, University of Pittsburgh Medical Center

Country where clinical trial is conducted

United States, 

References & Publications (1)

Palermo TM, Law EF, Topazian MD, Slack K, Dear BF, Ko YJ, Vege SS, Fogel E, Trikudanathan G, Andersen DK, Conwell DL, Yadav D; Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC). Internet Cognitive-Behavioral Therapy — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Treatment acceptability Participants will complete a 12-item Treatment Evaluation Inventory questionnaire that assesses satisfaction and acceptability of the course of treatment and satisfaction with the outcome of the intervention. Items are rated on a 5-point Likert scale ranging from 1 = Strongly disagree, to 5 = Strongly agree. Immediately post-treatment
Secondary Treatment feasibility Feasibility will be determined by calculating rates of accrual, drop out, compliance, and missing data. Criteria for feasibility success will be based on: accrual rates >70%, attrition rates <15%, minimal technical difficulties (i.e., reported by <10%), adherence rates >80%, and minimal missing data. Immediately post-treatment
Secondary Change in pain intensity Participants will report on presence and intensity of pain daily for 7 days at each assessment period. Pain intensity will be assessed using an 11-point numerical rating scale (NRS), where 0= no pain, and 10 = worst pain. Mean average intensity of the pain reported will serve as the pain measure. Baseline, 3-month follow-up
Secondary Change in pain-related disability Participants will report their level of pain-related disability daily for 7 days at each assessment period. Questions of pain-related disability are taken from the Brief Pain Inventory and the Pain Disability Index. These measures assess the extent to which chronic pain disrupts aspects of daily life including social relations, work, mood, sleep, eating, and physical activity. All items are scored on a 0-10 NRS, with higher scores indicating greater disability. Baseline, 3-month follow-up
Secondary Change in Disease specific and generic health related quality of life (HRQOL) Participants will complete the 18-item Pancreatitis Quality of Life Instrument to assess for disease-specific HRQOL difficulties. Items are scored on a 0-5 scale where 0 = Not applicable, 1 = Much less, and 5 = Much more. Participants will also complete the 12-item Short-Form Health Survey to assess for general HRQOL. Baseline, 3-month follow-up
Secondary Change in Medication use Participants will record their medication use daily for 7 days at each assessment period Baseline, 3-month follow-up
Secondary Change in Pain self-efficacy Participants will complete the 4-item Chronic Pain Self-Efficacy Scale. This scale assesses perceived self-efficacy over three factors: pain management, coping with symptoms, and physical function. All items are scored on a 7-point Likert scale where 0 = Not at all confident, and 6 = Completely confident Baseline, 3-month follow-up
Secondary Change in Psychological distress Participants will complete the 4-item Anxiety and 4-item Depression subscales of the Patient-Reported Outcomes Measurement Information System (PROMIS)-29 Profile to assess for levels of psychological distress over the past week. Items are scored on a 5-point Likert scale ranging from 1 = Never, to 5 = Always. Baseline, 3-month follow-up
Secondary Change in Sleep and Fatigue Participants will complete the 4-item Sleep Disturbance and 4-item Fatigue subscales of the PROMIS-29 Profile to assess for problems with fatigue and sleep over the previous week. All items are scored on a 5-point Likert scale ranging 1 = Not at all, to 5 = Very much, except for one sleep item which is scored 1 = very poor, to 5 = Very good. Baseline, 3-month follow-up
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05326542 - Comparison of Efficacy of ESWL and Laser Lithotripsy in Chronic Pancreatitis With ERCP N/A
Completed NCT01731821 - Nonstented Stump-closed vs Duct-to-Mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy Phase 3
Completed NCT01551511 - Δ9-THC (Namisol®) in Chronic Pancreatitis Patients Suffering From Persistent Abdominal Pain Phase 2
Active, not recruiting NCT05095831 - EUS Shear Wave for Solid Pancreatic Lesions.
Completed NCT03173118 - Elastography in the Diagnosis of Chronic Pancreatitis N/A
Terminated NCT01318590 - Prospective Study on Endoscopic Ultrasound (EUS) Celiac Bloc Efficacy in Chronic Pancreatitis Phase 3
Recruiting NCT05772234 - Aggressive Intravenous Hydration With Lactated Ringer's Solution for Prevention of Post-ESWL Pancreatitis N/A
Recruiting NCT04131010 - Digital Catheter Based Pancreatoscopy (SpyGlassDS) for the Management of Symptomatic Pancreatic Duct Stones in Selected Patients With Chronic Pancreatitis N/A
Terminated NCT00359320 - A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy N/A
Completed NCT02940067 - Enhancing Fitness Before Pancreatic Surgery N/A
Recruiting NCT05261997 - Endotherapy for Painless Chronic Pancreatitis N/A
Not yet recruiting NCT05270434 - Optimal Timing of Endoscopic Intervention in the Treatment of Chronic Pancreatitis. N/A
Completed NCT03672422 - Pediatric Longitudinal Cohort Study of Chronic Pancreatitis
Enrolling by invitation NCT05287737 - Clinical Outcome After Total Pancreatectomy With Islet Autotransplantation
Not yet recruiting NCT06426160 - Tocilizumab for Painful Chronic Pancreatitis Phase 2
Enrolling by invitation NCT05289362 - Comparison of Efficacy of Basket and Balloon in the Removal of Pancreatic Duct Stones in Chronic Pancreatitis Under ERCP N/A
Not yet recruiting NCT04760847 - Intermittent Fasting for Pancreatitis N/A
Enrolling by invitation NCT03228095 - Volatiles in Breath and Headspace Analysis - Diagnostic Markers
Completed NCT00956839 - Prospective Study of Efficacy of Intra-muscular Vitamin D3 in Tropical Calcific Pancreatitis Phase 4
Completed NCT00676702 - A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI) Phase 1